Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.01% Nasdaq Up0.31%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
7.63 Up 0.08(1.06%) Apr 17, 10:52AM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 17, 2014Alpha Street ResearchHunter OrrHALO - Halozyme Therapeutics Inc - Rated a Hold - Company Analysis and ASR Ranking Report9$24
Apr 16, 2014Pechala's ReportsLubomir PechalaHALOZYME THERAPEUTICS INC (HALO) - REPORT FOR ACTIVE TRADERS1$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for HALO11$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 16, 2014New Constructs, LLCN/AHALO: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 16, 2014S&P Capital IQ Quantitative ReportN/AHalozyme Therapeutics11$126.50
Apr 11, 2014Pechala's ReportsFrantisek PechalaHALOZYME THERAPEUTICS INC (HALO) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: FOLD , CNDO , HALO , OREX , GEVA , VNDA -- DRUGS3$34.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of HALOZYME THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: HALOZYME THERAP -- HALO1$11.50

View All Reports for HALO ...